CN102166325A - 一种治疗甲状腺功能亢进症的中药制备方法 - Google Patents
一种治疗甲状腺功能亢进症的中药制备方法 Download PDFInfo
- Publication number
- CN102166325A CN102166325A CN2010105508074A CN201010550807A CN102166325A CN 102166325 A CN102166325 A CN 102166325A CN 2010105508074 A CN2010105508074 A CN 2010105508074A CN 201010550807 A CN201010550807 A CN 201010550807A CN 102166325 A CN102166325 A CN 102166325A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- hyperthyroidism
- radix
- chinese medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 229940126678 chinese medicines Drugs 0.000 claims abstract description 5
- 241000195474 Sargassum Species 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 241000244155 Taenia Species 0.000 claims description 7
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 239000003643 water by type Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 abstract description 4
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 abstract description 3
- 208000001871 Tachycardia Diseases 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 229960002662 propylthiouracil Drugs 0.000 abstract description 3
- 230000006794 tachycardia Effects 0.000 abstract description 3
- 239000005495 thyroid hormone Substances 0.000 abstract description 3
- 229940036555 thyroid hormone Drugs 0.000 abstract description 3
- 206010033557 Palpitations Diseases 0.000 abstract description 2
- 206010037083 Prurigo Diseases 0.000 abstract description 2
- 206010037660 Pyrexia Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241001127714 Amomum Species 0.000 abstract 1
- 244000059800 Amomum compactum Species 0.000 abstract 1
- 235000016426 Amomum compactum Nutrition 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 240000004082 Bidens tripartita Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 240000002024 Gossypium herbaceum Species 0.000 abstract 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 241001038563 Pseudostellaria Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000027950 fever generation Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 26
- 210000004072 lung Anatomy 0.000 description 25
- 210000002784 stomach Anatomy 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 238000010792 warming Methods 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 230000004087 circulation Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 6
- 210000001685 thyroid gland Anatomy 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010018498 Goitre Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 201000003872 goiter Diseases 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020674 Hypermetabolism Diseases 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001936 exophthalmos Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040952 Skin warm Diseases 0.000 description 1
- 208000031353 Systolic Murmurs Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004090 etiopathogenesis Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105508074A CN102166325B (zh) | 2010-11-19 | 2010-11-19 | 一种治疗甲状腺功能亢进症的中药制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105508074A CN102166325B (zh) | 2010-11-19 | 2010-11-19 | 一种治疗甲状腺功能亢进症的中药制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102166325A true CN102166325A (zh) | 2011-08-31 |
| CN102166325B CN102166325B (zh) | 2013-03-20 |
Family
ID=44487768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105508074A Expired - Fee Related CN102166325B (zh) | 2010-11-19 | 2010-11-19 | 一种治疗甲状腺功能亢进症的中药制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166325B (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294015A (zh) * | 1999-10-26 | 2001-05-09 | 马俊杰 | 治疗甲状腺肿大甲亢的药物 |
| CN101152511A (zh) * | 2007-09-17 | 2008-04-02 | 李广欣 | 一种用于治疗甲亢病的药物及制备方法 |
-
2010
- 2010-11-19 CN CN2010105508074A patent/CN102166325B/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294015A (zh) * | 1999-10-26 | 2001-05-09 | 马俊杰 | 治疗甲状腺肿大甲亢的药物 |
| CN101152511A (zh) * | 2007-09-17 | 2008-04-02 | 李广欣 | 一种用于治疗甲亢病的药物及制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102166325B (zh) | 2013-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316208B (zh) | 具有补气养血、抗衰老、延年益寿的中药制剂 | |
| US20180055898A1 (en) | Traditional chinese medicine composition for preventing and treating externally diabetes and a method of using the same | |
| CN106474418A (zh) | 用于治疗胃病的中药组合物及其制备方法 | |
| CN103405658B (zh) | 一种治疗糖尿病的药物及其制备方法 | |
| CN102018928A (zh) | 一种治疗甲状腺功能减退症的中药制备方法 | |
| CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
| CN101376016B (zh) | 一种治疗高脂血症的中药制备方法 | |
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN102166310B (zh) | 一种治疗肝肾阴虚型甲状腺功能亢进症的中药制备方法 | |
| CN102302740A (zh) | 一种治疗心肾阴虚型胸痹的中药制备方法 | |
| CN101428114B (zh) | 一种治疗慢性乙肝、肝硬化和肝腹水的药物 | |
| CN1243561C (zh) | 一种治疗恶性肿瘤的中药 | |
| CN102166311B (zh) | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 | |
| CN102166309B (zh) | 一种治疗中焦蕴热型甲状腺功能亢进症的中药制备方法 | |
| CN102166325B (zh) | 一种治疗甲状腺功能亢进症的中药制备方法 | |
| CN111084820B (zh) | 一种用于治疗慢性肾脏病营养不良的中药组合物及其制备与应用 | |
| CN102166326B (zh) | 一种治疗肝郁肾虚型甲状腺功能亢进症的中药制备方法 | |
| CN106310137A (zh) | 一种治疗冠心病心绞痛气滞血瘀证的中药组合物 | |
| CN105963608A (zh) | 一种治疗ⅱ型糖尿病的中药 | |
| CN105250758A (zh) | 一种治疗糖尿病的中药组合物 | |
| CN104491621A (zh) | 一种治疗糖尿病的中药组合物 | |
| CN113679757B (zh) | 一种改善膀胱收缩力的药物组合物及其应用 | |
| CN102166327B (zh) | 一种治疗肝郁脾虚型甲状腺功能亢进症的中药制备方法 | |
| CN102058863B (zh) | 一种消除身体水肿的中药组合物 | |
| CN102935214A (zh) | 一种治疗尿毒症的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: DONG RUIXIANG Free format text: FORMER OWNER: LI DERU Effective date: 20130130 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Dong Ruixiang Inventor after: Yan Jingtang Inventor before: Li Deru |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250061 JINAN, SHANDONG PROVINCE TO: 272029 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI DERU TO: DONG RUIXIANG YAN JINGTANG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130130 Address after: 272029 Shandong city of Jining province Guhuai Road No. 79 Affiliated Hospital of Jining Medical College Applicant after: Dong Ruixiang Address before: 250061, No. 3, No. ten, No. 17531, 2-201, Shandong, Ji'nan Applicant before: Li Deru |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130320 Termination date: 20131119 |

